Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Libre 3 readings often run lower than a finger stick because the sensor measures glucose in interstitial fluid rather than blood, creating a natural lag of roughly 5 to 15 minutes that shows up most when your glucose is falling, after meals, during exercise, or overnight. Other common causes include a sensor that is still warming up in its first 24 hours, pressure-induced false lows from lying on the arm, dehydration, sensor placement or adhesion problems, and finger stick error from unwashed hands or an expired test strip. A difference of up to about 20 percent between the two methods is usually expected and not a malfunction, though persistent gaps that affect your treatment decisions deserve attention. There are several important factors and troubleshooting steps to consider, including when to trust the meter over the sensor and when to request a replacement, so see below to understand more.
If you are unsure whether your low readings reflect a sensor issue or a real change in your blood sugar, a free, instant, online symptom check can help you sort out what your symptoms suggest and decide whether to adjust, retest, or contact your care team today.
Last reviewed for medical accuracy: 09/13/2026
It can be frustrating to see your FreeStyle Libre 3 continuous glucose monitor (CGM) report lower values than your finger-stick meter. Understanding why these discrepancies happen can help you trust your data and manage your diabetes more confidently. Below is a breakdown of common reasons, how the Libre 3 works, and practical tips to reduce mismatches.
When your blood sugar changes quickly—after eating, exercising, dosing insulin or during stress—the interstitial fluid takes a bit longer to reflect those changes.
This lag is normal and expected with all CGMs. Over time, the Libre 3’s algorithm adjusts to reduce this gap, but it can’t eliminate it entirely.
Several real-world factors may lead your Libre 3 to read lower than a finger stick:
Sensor Placement
– Avoid areas with poor circulation, scars or thick fatty tissue.
– Ideal site: back of the upper arm, clean and dry.
Compression Artifacts
– Lying on the sensor (e.g., sleeping with your arm under your body) may “compress” it, causing falsely low readings.
– Try to rotate sleeping positions and avoid pressure on the sensor area.
Hydration and Sweat
– Dehydration can reduce interstitial fluid and concentrate glucose readings.
– Excessive sweating (after a workout) may interfere with sensor-skin contact.
Temperature Extremes
– Very hot or cold skin can alter sensor accuracy.
– Keep the sensor covered in cold weather, avoid direct heat sources (saunas, heating pads).
Rapid Glucose Changes
– After a high-carb meal or intense exercise, blood sugar can rise/fall faster than the Libre 3 can track.
– Expect a temporary gap; wait 10–15 minutes for the sensor to catch up.
Medication Interference
– High doses of vitamin C, acetaminophen (paracetamol) or other substances may affect some CGMs.
– Check with your healthcare provider or your Libre 3 instruction manual.
Manufacturers report CGM accuracy using metrics like MARD (Mean Absolute Relative Difference). For the Libre 3:
Even with perfect technique, CGMs and finger sticks can’t replace a healthcare professional’s judgment. If you experience:
…consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help decide if you should speak to a healthcare provider.
Never ignore serious symptoms based on a single device reading. If anything could be life-threatening or deeply concerning—speak to a doctor right away. Your healthcare professional can help interpret your data, adjust your plan and ensure you’re getting the best possible care.
(References)
* Strategies to Enhance New CGM Use in Early Childhood (SENCE) Study Group. A Randomized Clinical Trial Assessing Continuous Glucose Monitoring (CGM) Use With Standardized Education With or Without a Family Behavioral Intervention Compared With Fingerstick Blood Glucose Monitoring in Very Young Children With Type 1 Diabetes. Diabetes Care. 2021 Feb;44(2):464-472. doi: 10.2337/dc20-1060. Epub 2020 Dec 17. PMID: 33334807; PMCID: PMC9162100.
* Lin R, Brown F, James S, Jones J, Ekinci E. Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus. Diabet Med. 2021 May;38(5):e14528. doi: 10.1111/dme.14528. Epub 2021 Mar 6. PMID: 33496979.
* Garg SK, Kipnes M, Castorino K, Bailey TS, Akturk HK, Welsh JB, Christiansen MP, Balo AK, Brown SA, Reid JL, Beck SE. Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes. Diabetes Technol Ther. 2022 Jun;24(6):373-380. doi: 10.1089/dia.2022.0011. Epub 2022 Feb 21. PMID: 35157505; PMCID: PMC9208857.
* Keshet A, Shilo S, Godneva A, Talmor-Barkan Y, Aviv Y, Segal E, Rossman H. CGMap: Characterizing continuous glucose monitor data in thousands of non-diabetic individuals. Cell Metab. 2023 May 2;35(5):758-769.e3. doi: 10.1016/j.cmet.2023.04.002. Epub 2023 Apr 19. PMID: 37080199.
* Lu J, Ying Z, Wang P, Fu M, Han C, Zhang M. Effects of continuous glucose monitoring on glycaemic control in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2024 Jan;26(1):362-372. doi: 10.1111/dom.15328. Epub 2023 Oct 12. PMID: 37828805.
* Uhl S, Choure A, Rouse B, Loblack A, Reaven P. Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials. J Clin Endocrinol Metab. 2024 Mar 15;109(4):1119-1131. doi: 10.1210/clinem/dgad652. PMID: 37987208.
* Ferreira ROM, Trevisan T, Pasqualotto E, Chavez MP, Marques BF, Lamounier RN, van de Sande-Lee S. Continuous Glucose Monitoring Systems in Noninsulin-Treated People with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diabetes Technol Ther. 2024 Apr;26(4):252-262. doi: 10.1089/dia.2023.0390. Epub 2024 Feb 13. PMID: 38090767.
* Klonoff DC, Gabbay M, Moon SJ, Wilmot EG. Importance of FDA-Integrated Continuous Glucose Monitors to Ensure Accuracy of Continuous Glucose Monitoring. J Diabetes Sci Technol. 2025 Sep;19(5):1392-1399. doi: 10.1177/19322968241250357. Epub 2024 May 3. PMID: 38695387; PMCID: PMC11571640.
* Battarbee AN, Durnwald C, Yee LM, Valent AM. Continuous Glucose Monitoring for Diabetes Management During Pregnancy: Evidence, Practical Tips, and Common Pitfalls. Obstet Gynecol. 2024 Nov 1;144(5):649-659. doi: 10.1097/AOG.0000000000005669. Epub 2024 Jul 17. PMID: 39016319; PMCID: PMC11486575.
* Lau D, Manca DP, Singh P, Perry T, Olu-Jordan I, Ryan Zhang J, Rahim G, Hagen EM, Yeung RO. The effectiveness of continuous glucose monitoring with remote telemonitoring-enabled virtual educator visits in adults with non-insulin dependent type 2 diabetes: A randomized trial. Diabetes Res Clin Pract. 2024 Nov;217:111899. doi: 10.1016/j.diabres.2024.111899. Epub 2024 Oct 19. PMID: 39433218.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.